In 2024, cannabis legalization made significant strides, with 24 U.S. states allowing recreational use and Nebraska passing medical marijuana laws. However, Florida and other states faced challenges in legalizing recreational measures. Internationally, Germany led Europe by legalizing possession and home-growing of cannabis, establishing a model for reform. Despite advancements, challenges such as unlicensed dispensaries in states like New York and health risks like Cannabis Hyperemesis Syndrome cast a shadow on progress. Notably, the DEA's recommendation to reschedule cannabis could change the research landscape significantly, underscoring shifting perceptions of cannabis' medical value.
In the U.S., 2024 saw cannabis legalization expand to 24 states, yet states like Florida and the Dakotas faced setbacks in passing recreational measures.
Germany became a pioneer in Europe for cannabis reform by legalizing limited use, allowing adults to possess and grow cannabis, setting a precedent.
Despite progress, challenges like unlicensed dispensaries in New York and health concerns such as Cannabis Hyperemesis Syndrome complicate the cannabis landscape.
The DEA's proposal to reschedule cannabis could signal a significant change in U.S. cannabis policy, simplifying research and recognizing its medical potential.
Collection
[
|
...
]